Fonte: JBI Database of Systematic Reviews and Implementation Reports. Unidade: EE
Assuntos: CUSTOS DOS CUIDADOS DE SAÚDE, INFECÇÕES BACTERIANAS, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Wendel Mombaque dos et al. Cost-effectiveness of antimicrobial treatment for inpatients with carbapenem-resistant Klebsiella pneumoniae infection: a systematic review of economic evidence. JBI Database of Systematic Reviews and Implementation Reports, v. 17, n. 12, p. 2417-2451, 2019Tradução . . Disponível em: https://doi.org/10.11124/JBISRIR-D-18-00019. Acesso em: 01 nov. 2024.APA
Santos, W. M. dos, Aromataris, E., Secoli, S. R., & Matuoka, J. Y. (2019). Cost-effectiveness of antimicrobial treatment for inpatients with carbapenem-resistant Klebsiella pneumoniae infection: a systematic review of economic evidence. JBI Database of Systematic Reviews and Implementation Reports, 17( 12), 2417-2451. doi:10.11124/JBISRIR-D-18-00019NLM
Santos WM dos, Aromataris E, Secoli SR, Matuoka JY. Cost-effectiveness of antimicrobial treatment for inpatients with carbapenem-resistant Klebsiella pneumoniae infection: a systematic review of economic evidence [Internet]. JBI Database of Systematic Reviews and Implementation Reports. 2019 ; 17( 12): 2417-2451.[citado 2024 nov. 01 ] Available from: https://doi.org/10.11124/JBISRIR-D-18-00019Vancouver
Santos WM dos, Aromataris E, Secoli SR, Matuoka JY. Cost-effectiveness of antimicrobial treatment for inpatients with carbapenem-resistant Klebsiella pneumoniae infection: a systematic review of economic evidence [Internet]. JBI Database of Systematic Reviews and Implementation Reports. 2019 ; 17( 12): 2417-2451.[citado 2024 nov. 01 ] Available from: https://doi.org/10.11124/JBISRIR-D-18-00019